Steve Pakola, Chief Medical Officer, on June 29, 2026, sold 56,333 shares in Regenxbio (RGNX) for $688,756. Following the Form 4 filing with the SEC, Pakola has control over a total of 213,009 common shares of the company, with 213,009 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1590877/000170065926000012/xslF345X05/primarydocument.xml
Chris Koopmans, President and COO, on July 01, 2026, sold 10,000 shares in Marvell Technology (MRVL) for $2,819,200. Following the Form 4 filing with the SEC, Koopmans has control over a total of 227,754 common shares of the company, with 227,754 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1835632/000162828026046627/xslF345X05/wk-form4_1782942422.xml
Cole G. Carter, Chief Administrative Officer, on July 01, 2026, sold 12,500 shares in Corecivic (CXW) for $380,750. Following the Form 4 filing with the SEC, Carter has control over a total of 203,383 common shares of the company, with 203,383 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1070985/000119312526292852/xslF345X05/ownership.xml
Tim Truels Hansen, Chief Commercial Officer, on June 30, 2026, sold 20,000 shares in Dorian LPG (LPG) for $707,526. Following the Form 4 filing with the SEC, Hansen has control over a total of 157,842 common shares of the company, with 157,842 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1596993/000091957426004215/xslF345X05/ownership.xml